Treatment of Bacterial Vaginosis With Oral Tinidazole

Last updated: March 21, 2017
Sponsor: Mission Pharmacal
Overall Status: Completed

Phase

3

Condition

Gynecological Infections

Sexually Transmitted Diseases (Stds)

Vaginitis

Treatment

N/A

Clinical Study ID

NCT00229216
T-500
  • Ages > 18
  • Female

Study Summary

The purpose of this study is to confirm the safety and efficacy of oral tinidazole for the treatment of bacterial vaginosis.

Eligibility Criteria

Inclusion

Inclusion Criteria: Clinical and microbiological diagnosis of bacterial vaginosis -

Exclusion

Exclusion Criteria: Other sexually transmitted disease

Study Design

Total Participants: 200
Study Start date:
January 01, 2005
Estimated Completion Date:
June 30, 2007

Study Description

Tinidazole is a second-generation nitroimidazole i.e. an updated form of the standard drug used to treat bacterial vaginosis (metronidazole). Two dosing regimens are being compared to placebo to treat bacterial vaginosis, one of the most common vaginal infections.

Connect with a study center

  • Duke University School of Medicine

    Durham, North Carolina 27710
    United States

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.